Get Real with Jim Weiss Podcast Por Jim Weiss arte de portada

Get Real with Jim Weiss

Get Real with Jim Weiss

De: Jim Weiss
Escúchala gratis

Acerca de esta escucha

 As the founder of internationally acclaimed global health innovation company Real Chemistry, Jim Weiss knows that the key to success and leveraging one's mission is connection -- so he's reached out to innovators in and outside of healthcare to discuss what's now and what's next. He's interviewing world-renowned scientists, CEOs, public health experts, and the list goes on! It's time to GET REAL about the future of healthcare and how to be better health citizens.005199 Ciencias Sociales Hygiene & Healthy Living
Episodios
  • Episode Seventeen: Oriana Kraft, Founder of ORI

    Episode Seventeen: Oriana Kraft, Founder of ORI
    May 5 2025
    In this episode of Get Real, Jim sits down with Oriana Kraft, the Founder of ORI. She is transforming women's healthcare through data-driven solutions and employer partnerships. After discovering alarming gaps in medical education and clinical research, Oriana turned her thesis project into a global movement dedicated to translating women's health research into practical care solutions. The conversation examines the economic costs of overlooking women's health issues in the workplace, the systemic barriers that prevent adequate care, and how employers can create more supportive environments while improving their bottom line. Oriana offers many innovative approaches that could finally close the gender health gap. What You'll Learn: How a staggering 70% of female employees lose 1-5 workdays monthly due to women's health issues, and the $3,000 per woman cost to employers who don't address these needs The economic and structural factors driving healthcare inequality Practical strategies employers can implement to create stigma-free environments for women's health discussions while improving productivity and retention How AI and data-driven approaches are revolutionizing women's healthcare design, creating opportunities for better diagnosis, treatment, and workplace support systems
    Más Menos
    30 m
  • Episode Sixteen: Dr. Lennard Lee, Chief Medical Officer at the Ellison Institute of Technology & Co-Founder of the NHS Cancer Vaccine Launchpad

    Episode Sixteen: Dr. Lennard Lee, Chief Medical Officer at the Ellison Institute of Technology & Co-Founder of the NHS Cancer Vaccine Launchpad
    Apr 7 2025
    Dr. Lennard Lee is a force of nature in medicine. He is the Chief Medical Office at the Ellison Institute of Technology. Since 2020, he has led groundbreaking national programs that unite scientists, clinicians, and policymakers to advance the development of cancer vaccines. Dr. Lee co-founded the NHS Cancer Vaccine Launchpad, an initiative designed to streamline patient enrollment in cancer vaccine trials. He's spearheading efforts to enroll 10,000 patients by 2030, accelerating trials and ensuring the latest breakthroughs reach those in need. His work has earned him top honors such as the ACP McElwain Prize, IAP Outstanding Young Physicians Award, DSIT Superhero Award, and the UK Science & Engineering Infinity Award. In this episode, you'll learn: How he built the NHS Cancer Vaccine Launchpad The UK's role in global cancer vaccine development and clinical research Insights into successful cancer vaccine trials, including promising results from Devon The risk-benefit analysis of shifting to a vaccine-first approach for cancer treatment Current progress and breakthroughs in cancer vaccine clinical trials How research and development investments are being managed to sustain innovation Dr. Lee's predictions for when preventative cancer vaccines might become widely available Strategies for ensuring global access and affordability of cancer vaccine technologies How collaboration between pharma and biotech is accelerating innovation The evolution of cancer staging and diagnostics in a vaccine-driven treatment landscape
    Más Menos
    33 m
  • Episode Fifteen: Alicia Zhou CEO of Cancer Research Institute

    Episode Fifteen: Alicia Zhou CEO of Cancer Research Institute
    Mar 10 2025
    Dr. Alicia Zhou is the CEO of the Cancer Research Institute (CRI), an organization at the forefront of cancer innovation. With backgrounds in academia, healthcare, and nonprofits, she brings a unique perspective to the table. Today, she's heading into the future…of cancer research—what’s changing and what’s holding it back. From advancements in immunotherapy to barriers—healthcare costs, diversity in research, and even politics, Alicia shares her real take on the opportunities and challenges. She's discussing AI’s role in early diagnosis and prevention and how data-driven tools are making precision medicine more equitable. In this episode, you’ll learn: What CRI is and how its mission is shaping the future of cancer research Dr. Zhou’s vision for CRI and where she hopes to drive impact Why this year’s Nobel Prize in Chemistry is a game-changer for STEM fields The differences between chemotherapy and immunotherapy—and what’s next The most significant breakthroughs in immunology that are changing cancer treatment Why early detection is critical and how screening practices need to evolve How AI and data analytics are revolutionizing cancer care and precision medicine The barriers holding back progress in immunotherapy and how to overcome them
    Más Menos
    35 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones